Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Benign neonatal hemangiomatosis

J K Stern, J E Wolf, M Jarratt

    Journal of the American Academy of Dermatology
    |April 1, 1981
    PubMed
    Summary

    Diffuse neonatal hemangiomatosis is a severe condition affecting newborns, characterized by widespread hemangiomas and potential organ damage. However, some infants may experience a benign form with spontaneous resolution, termed benign neonatal hemangiomatosis.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Photodynamic therapy with methyl aminolaevulinate 80 mg g(-1) for severe facial acne vulgaris: a randomized vehicle-controlled study.

    The British journal of dermatology·2015
    Same author

    Treatment of facial erythema in patients with rosacea with topical brimonidine tartrate: correlation of patient satisfaction with standard clinical endpoints of improvement of facial erythema.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2014
    Same author

    What do French patients and geneticists think about prenatal and preimplantation diagnoses in Marfan syndrome?

    Prenatal diagnosis·2012
    Same author

    Once-daily topical brimonidine tartrate gel 0·5% is a novel treatment for moderate to severe facial erythema of rosacea: results of two multicentre, randomized and vehicle-controlled studies.

    The British journal of dermatology·2011
    Same author

    The new Ghent criteria for Marfan syndrome: what do they change?

    Clinical genetics·2011
    Same author

    A 6-month maintenance therapy with adapalene-benzoyl peroxide gel prevents relapse and continuously improves efficacy among patients with severe acne vulgaris: results of a randomized controlled trial.

    The British journal of dermatology·2011

    Area of Science:

    • Pediatric vascular anomalies
    • Neonatal multisystem syndromes
    • Dermatology and Hematology

    Background:

    • Diffuse neonatal hemangiomatosis (DNH) is a rare but serious condition.
    • It presents as a multisystem syndrome involving skin, organs, and the central nervous system.
    • Key features include multiple hemangiomas, arteriovenous shunts, heart failure, and bleeding disorders.

    Observation:

    • Some neonates exhibit numerous cutaneous hemangiomas but follow a benign clinical course.
    • These cases may resolve spontaneously without significant visceral complications.
    • This distinct presentation is termed benign neonatal hemangiomatosis.

    Findings:

    • DNH involves significant arteriovenous shunting, leading to high-output congestive heart failure.
    • Thrombocytopenia with hemorrhage is a common and dangerous complication.
    • Central nervous system involvement can lead to neurological deficits.

    Implications:

    • Distinguishing between severe DNH and benign neonatal hemangiomatosis is crucial for appropriate management.
    • Early recognition of benign cases can prevent unnecessary aggressive treatments.
    • Understanding the spectrum of neonatal hemangiomatosis aids in predicting outcomes and guiding therapy.

    Related Experiment Videos